| |
|
|
|
Aslan Pharmaceuticals Ltd ADR  
|
|
2.0799 -0.09 (-0.04%) |
01-25 12:17 |
|
Open: |
2.16 |
Pre close: |
2.17 |
Target:
|
2.55
|
|
High: |
2.17 |
Low: |
2.05 |
Resistance:
|
2.18
2.55
|
|
Volume: |
152,700 |
Market Cap: |
79M |
Support:
|
1.95
1.80
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.11
 |
MACD |
MACD(12,26):
|
0.05  |
|
MA(20): |
1.98 |
Signal(12,26,9): |
0.04 |
|
MA(100): |
1.81 |
Stochastic Oscillator |
%K(14,3):
|
87.62 |
|
MA(250): |
1.75 |
%D(3): |
88.79 |
|
Average Volume(K) |
3-Month: |
33620
|
52-Week |
High:
|
2.50 |
|
10-Days: |
27216 |
Low: |
0.83 |
|
RSI |
RSI(14):
|
55.35 |
Change(%): |
-4.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.167 |
Return on Equity (ttm) |
-6043.7 |
Shares Out. (M) |
37.99 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-49.3 |
Shares Float (M) |
37.99 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
10.72 |
|
Forward EPS |
-0.280 |
Gross Profit (p.s.) |
2.101 |
Shares Short (K) |
28 |
|
Book Value (p.s.) |
-0.320 |
EBITDA (p.s.) |
-0.472 |
P/E |
-1.77 |
|
Sales Per Share |
0.005 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-6.47 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
414.52 |
|
Operating Margin |
-9481.98 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
